DAFNA Capital Management’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

DAFNA Capital Management’s Portfolio CYNA Stock Details CYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-230,201	Closed	-$9.26M	–	83
2016 Q3	$9.26M	Buy	230,201 +7,842	+4%	+$194K	6.45%	2
2016 Q2	$3.72M	Buy	222,359 +169,418	+320%	+$2.28M	2.95%	9
2016 Q1	$646K	Buy	52,941 +6,312	+14%	+$84.5K	0.56%	52
2015 Q4	$722K	Buy	46,629 +1,805	+4%	+$27.4K	0.64%	43
2015 Q3	$707K	Sell	44,824 -50,000	-53%	-$812K	0.7%	41
2015 Q2	$1.73M	Buy	+94,824	New	+$1.56M	1.46%	24

DAFNA Capital Management's CYNA Position: Q4 2016 in Review

DAFNA Capital Management sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 230,201 shares — an estimated $9.26M sold.

DAFNA Capital Management first reported a position in CYNA in Q2 2015 and held it in 6 quarters. The position peaked at $9.26M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

DAFNA Capital Management reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
DAFNA Capital Management sold 230,201 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $9.26M.
DAFNA Capital Management first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 6 quarters.
DAFNA Capital Management's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $9.26M in Q3 2016.
0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on DAFNA Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.